findmyKOL

Emma Punni, MD

Basic profile

University of Oklahoma Health Sciences Center

ORCIDNPI
RegionOklahoma City, OK · South CentralSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Emma Punni is an Endocrinology/Metabolic physician affiliated with University of Oklahoma Health Sciences Center. OpenAlex indexes 15 publications with 218 citations (h-index 3).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
15publications

Distinct works indexed by OpenAlex, matched via ORCID.

218citations

Total citations across indexed works.

3h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1000 N Lincoln Blvd Ste 2900
Oklahoma City, OK 73104

Telephone

405-271-5896

Registry record last updated 8 Jun 2018.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    63%
    GLP-1 receptor agonist23.3%
    Mounjaro38%Trulicity32%Ozempic30%
    Part D14 patients
    Insulin Analog16.2%
    Lantus Solostar26%Humalog Kwikpen U-10017%Novolog Flexpen14%Novolog13%Tresiba Flextouch U-10012%Toujeo Solostar9%Humalog9%
    Part D<11 patients

    + 5 more classes in this area

  • Hormonal (systemic)

    16.1%
    l-Thyroxine14.3%
    Levothyroxine Sodium100%
    Part D37 patients
    Thyroid Hormone Synthesis Inhibitor1.8%
    Methimazole100%
    Part D<11 patients
  • Cardiovascular

    10.6%
    Statin6.9%
    Atorvastatin Calcium80%Pravastatin Sodium20%
    Part D<11 patients
    ACE inhibitor1.9%
    Lisinopril100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)18.7% facility · 81.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”